A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate Cancer.


Journal

European urology oncology
ISSN: 2588-9311
Titre abrégé: Eur Urol Oncol
Pays: Netherlands
ID NLM: 101724904

Informations de publication

Date de publication:
07 2019
Historique:
received: 16 07 2018
revised: 29 08 2018
accepted: 16 09 2018
entrez: 7 7 2019
pubmed: 7 7 2019
medline: 30 5 2020
Statut: ppublish

Résumé

Researchers remain divided on the major causes of dropout from active surveillance (AS), with rates of up to 38% among men with no evidence of prostate cancer (PC) progression. To develop and evaluate an educational intervention in terms of adherence to AS among men with low- to intermediate-risk PC. We first carried out focus group discussions with men who had remained on and dropped out of AS to inform an intervention to increase adherence to AS. A total of 255 consecutive men who had selected AS were then recruited to either standard care (written information and access to a nurse specialist) or standard care and the intervention. An educational seminar was designed by patients and clinicians including information on imaging, biopsy techniques, understanding pathology, large AS cohorts - mortality and morbidity risk and diet and lifestyle advice. The proportion of men dropping out of AS for reasons other than disease progression was assessed at 1 and 5yr after AS selection using multivariate logistic regression. Common themes influencing decision-making by men on AS were identified: (1) clinical consistency; (2) information; and (3) lifestyle advice. Addition of an educational seminar led to significantly fewer men dropping out of AS: at 1 and 5yr the dropout rate was 25% and 42%, respectively, in the standard care group, compared to 11% and 22% (p=0.001) in the intervention group. In the intervention group, 18 men failed to attend the seminar. The AS dropout rate was halved following a single educational seminar delivered to groups of men with intermediate- or low-risk PC, even at 5yr. Men on active surveillance (AS) for prostate cancer feel more supported when provided with an educational seminar within 3 mo of their treatment choice. The seminar halved the number of men dropping-out of AS, even at 5yr.

Sections du résumé

BACKGROUND
Researchers remain divided on the major causes of dropout from active surveillance (AS), with rates of up to 38% among men with no evidence of prostate cancer (PC) progression.
OBJECTIVE
To develop and evaluate an educational intervention in terms of adherence to AS among men with low- to intermediate-risk PC.
DESIGN, SETTING, AND PARTICIPANTS
We first carried out focus group discussions with men who had remained on and dropped out of AS to inform an intervention to increase adherence to AS. A total of 255 consecutive men who had selected AS were then recruited to either standard care (written information and access to a nurse specialist) or standard care and the intervention.
INTERVENTION
An educational seminar was designed by patients and clinicians including information on imaging, biopsy techniques, understanding pathology, large AS cohorts - mortality and morbidity risk and diet and lifestyle advice.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
The proportion of men dropping out of AS for reasons other than disease progression was assessed at 1 and 5yr after AS selection using multivariate logistic regression.
RESULTS AND LIMITATIONS
Common themes influencing decision-making by men on AS were identified: (1) clinical consistency; (2) information; and (3) lifestyle advice. Addition of an educational seminar led to significantly fewer men dropping out of AS: at 1 and 5yr the dropout rate was 25% and 42%, respectively, in the standard care group, compared to 11% and 22% (p=0.001) in the intervention group. In the intervention group, 18 men failed to attend the seminar.
CONCLUSIONS
The AS dropout rate was halved following a single educational seminar delivered to groups of men with intermediate- or low-risk PC, even at 5yr.
PATIENT SUMMARY
Men on active surveillance (AS) for prostate cancer feel more supported when provided with an educational seminar within 3 mo of their treatment choice. The seminar halved the number of men dropping-out of AS, even at 5yr.

Identifiants

pubmed: 31277784
pii: S2588-9311(18)30167-6
doi: 10.1016/j.euo.2018.09.007
pii:
doi:

Types de publication

Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-470

Informations de copyright

Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Netty Kinsella (N)

Department of Uro-Oncology, The Royal Marsden Hospital, London, UK; Translational Oncology and Urology Research, King's College London, London, UK; Centre for Population Health Research, University of South Australia, Adelaide, Australia. Electronic address: netty.kinsella@rmh.nhs.uk.

Kerri Beckmann (K)

Translational Oncology and Urology Research, King's College London, London, UK; Centre for Population Health Research, University of South Australia, Adelaide, Australia; Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK.

Declan Cahill (D)

Department of Uro-Oncology, The Royal Marsden Hospital, London, UK.

Oussama Elhage (O)

Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK; MRC Transplantation, King's College London, London, UK.

Rick Popert (R)

Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK.

Paul Cathcart (P)

Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK.

Ben Challacombe (B)

Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK.

Christian Brown (C)

Department of Urology, Guys and St. Thomas NHS Foundation Trust, London, UK; Department of Urology, Kings Hospital, London, UK.

Mieke Van Hemelrijck (M)

Translational Oncology and Urology Research, King's College London, London, UK; Centre for Population Health Research, University of South Australia, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH